Oncology & Cancer
These foods may up your odds for colon cancer
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.
Jan 18, 2018
0
71
JAMA Oncology
Oncology & Cancer
Corynebacterium, Kingella abundance tied to HNSCC risk
(HealthDay)—The overall oral microbiome composition is not associated with the risk of head and neck squamous cell carcinoma (HNSCC), but greater abundance of genera Corynebacterium and Kingella is associated with decreased ...
Jan 12, 2018
0
4
Oncology & Cancer
Breast implants slightly increase risk of breast ALCL
(HealthDay)—Breast implants are associated with an increased risk of anaplastic large-cell lymphoma in the breast (breast-ALCL), though the absolute risk is small, according to a study published online Jan. 4 in JAMA Oncology.
Jan 5, 2018
0
3
Oncology & Cancer
Small-cell lung cancer patients face barriers to receiving standard-of-care treatment
Despite decades of clinical research establishing chemotherapy with thoracic radiation as the standard-of-care for the initial management of non-metastatic small-cell lung cancer (SCLC), a large percentage of U.S. patients ...
Jan 4, 2018
0
5
Oncology & Cancer
Few immuno-oncology agents reach ASCO efficacy thresholds
(HealthDay)—Few modern, U.S. Food and Drug Administration-approved immuno-oncology agents have durable survival and response rates that are deemed significant by the American Society of Clinical Oncology (ASCO) value framework, ...
Jan 3, 2018
0
1
Oncology & Cancer
Carfilzomib can lead to cardiovascular toxicity in multiple myeloma patients
The proteasome inhibitor carfilzomib has taken on an increasing role in the treatment of multiple myeloma, but new research from the Abramson Cancer Center of the University of Pennsylvania shows the therapy comes with the ...
Dec 28, 2017
0
6
Oncology & Cancer
Normalized post-op CEA may help predict colon cancer prognosis
(HealthDay)—Colon cancer patients with elevated preoperative carcinoembryonic antigen (CEA) levels that normalize after resection are not at increased risk for poor prognosis, according to a study published online Dec. ...
Dec 26, 2017
0
7
Oncology & Cancer
Liquid biopsy results differed substantially between two providers
Two Johns Hopkins prostate cancer researchers found significant disparities when they submitted identical patient samples to two different commercial liquid biopsy providers. Liquid biopsy is a new and noninvasive alternative ...
Dec 14, 2017
0
12
Oncology & Cancer
Testing the accuracy of FDA-approved and lab-developed cancer genetics tests
Cancer molecular testing can drive clinical decision making and help a clinician determine if a patient is a good candidate for a targeted therapeutic drug. Clinical tests for common cancer causing-mutations in the genes ...
Dec 14, 2017
0
7
Oncology & Cancer
No increase in seizure incidence with enzalutamide in mCRPC
(HealthDay)—For patients with metastatic castration-resistant prostate cancer (mCRPC) with at least one risk factor for seizure at baseline, treatment with enzalutamide is not associated with increased incidence of seizure, ...
Dec 8, 2017
0
0
